R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Can technology help diversify clinical trials?

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials.

R&D

Why are clinical trials struggling with diversity?

In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative.

Patients

Conducting successful commercial research in a primary care ...

The primary care setting has garnered significant attention from industry stakeholders due to its promise in commercial research.

R&D

Close up of doctor writing on a medical chart.

On Clinical Trials Day, CVS shares lessons learned from one ...

CVS Health has come a long way from its humble beginnings as a health and beauty products store in 1963.

R&D

Digital-health-is-not-about-big-data–it-is-about-people

Unlocking the potential of healthcare data in research

Health data research in the UK is rapidly evolving, with new capabilities emerging through the rise of hybrid engagement and the accelerated adoption of digital technologies.

R&D

Recent advances in neurological disorders

Considerable scientific progress across neurological diseases and disorders was reported at the recent 74th American Academy of Neurology (AAN) Annual Meeting.